Complications in Minimally Invasive Aesthetic Dermatological Procedures in Switzerland
NCT ID: NCT06864871
Last Updated: 2025-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2021-01-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Effectiveness Clinical Evaluation of Injectable Medical Devices Viscol
NCT06142643
In-use Tolerance and Efficacy Study Under Dermatological Control of an Anti-aging Cream (Split Face) Post Facial Superficial Rejuvenation Procedures, After re Epidermization
NCT06942403
Safety and Efficacy of Lip Injections With Emervel Lips and Juvederm Ultra Smile
NCT01745250
Study of JTM104 Injection vs. Juvederm in Treating Moderate to Severe Nasolabial Folds
NCT07265791
Safety and Effectiveness Clinical Evaluation of Injectable Medical Devices
NCT06142578
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
With the increase in aesthetic procedures, adverse effects have also increased. Contributing factors include weak regulations, unlicensed practice, and individuals with little or no formal training administering botulinum toxins and dermal fillers.
This study aims to analyze unexpected and often unfavorable outcomes, referred to as complications, arising from minimally invasive procedures-both non-injectable (e.g., laser treatments, chemical peels) and injectable (e.g., botulinum toxin, fillers). The complications are categorized based on their severity and ethiology. This retrospective case series is conducted at a university reference center in Switzerland (Margarethenklinik of the University Hospital Basel) between January 2021 and December 2024.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients under 18 years old.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roberta Vasconcelos Berg, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Margarethenklinik, University Hospital Basel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Margarethenklinik, University Hospital Basel
Basel, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-00297; th25Vasconcelos
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.